Journal Article

Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma

Zhang, Yuqin, Wang, Kunyuan, Chen, Ying, Xie, Qiankun, Zhang, Han, Guo, Yuetong, Xie, Guozhu, Sun, Yao, Sugimura, Ryohichi, Liu, Zishen, Wang, Fei, Dong, Xin, Lin, Xiaotong, Guo, Zhaoze, Ling, Jing, Xiang, Hongjin

2024

Overview

Background Chimeric antigen receptor (CAR)-NK cell therapy has shown remarkable clinical efficacy and safety in the treatment of hematological malignancies. However, this efficacy was limited in solid tumors owing to hostile tumor microenvironment (TME). Radiotherapy is commonly used for solid tumors and proved to improve the TME. Therefore, the combination with radiotherapy would be a potential strategy to improve therapeutic efficacy of CAR-NK cells for solid tumors. Methods Glypican-3 (GPC3) was used as a target antigen of CAR-NK cell for hepatocellular carcinoma (HCC). To promote migration towards HCC, CXCR2-armed CAR-NK92 cells targeting GPC3 were first developed, and their cytotoxic and migration activities towards HCC cells were evaluated. Next, the effects of irradiation on the anti-tumor activity of CAR-NK92 cells were assessed in vitro and in HCC-bearing NCG mice. Lastly, to demonstrate the potential mechanism mediating the sensitized effect of irradiation on CAR-NK cells, the differential gene expression profiles induced by irradiation were analyzed and the expression of some important ligands for the NK-cell activating receptors were further determined by qRT-PCR and flow cytometry. Results In this study, we developed CXCR2-armed GPC3-targeting CAR-NK92 cells that exhibited specific and potent killing activity against HCC cells and the enhanced migration towards HCC cells. Pretreating HCC cells with irradiation enhanced in vitro anti-HCC effect and migration activity of CXCR2-armed CAR-NK92 cells. We further found that only high-dose (8 Gy) but not low-dose (2 Gy) irradiation in one fraction could significantly enhanced in vivo anti-HCC activity of CXCR2-armed CAR-NK92 cells. Irradiation with 8 Gy significantly up-regulated the expression of NK cell-activating ligands on HCC cells. Conclusions Our results indicate the evidence that irradiation could efficiently enhance the anti-tumor effect of CAR-NK cells in solid tumor model. The combination with radiotherapy would be an attractive strategy to improve therapeutic efficacy of CAR-NK cells for solid tumors.

• Publisher: BioMed Central,BioMed Central Ltd,BMC
• Subject: Analysis / Animals / Biomedical and Life Sciences / Biomedicine / Carcinoma, Hepatocellular - immunology / Carcinoma, Hepatocellular - pathology / Carcinoma, Hepatocellular - radiotherapy / Carcinoma, Hepatocellular - therapy / Care and treatment / Cell Line, Tumor / Cell Movement - radiation effects / Combination strategies / Cytotoxicity, Immunologic - radiation effects / Diagnosis / Gene expression / Gene Expression Regulation, Neoplastic - radiation effects / Genetic aspects / Glypicans - metabolism / Hepatoma / Humans / Immunotherapy / Immunotherapy, Adoptive - methods / Killer Cells, Natural - immunology / Killer Cells, Natural - radiation effects / Liver Neoplasms - immunology / Liver Neoplasms - pathology / Liver Neoplasms - radiotherapy / Liver Neoplasms - therapy / Medicine/Public Health / Mice / Patient outcomes / Radiotherapy / Receptors, Chimeric Antigen - metabolism / Receptors, Interleukin-8B - metabolism / Tumor Microenvironment - radiation effects / Xenograft Model Antitumor Assays